-
Spyre Therapeutics, Inc. (NASDAQ:SYRE) Given Average Recommendation of "Buy" by Brokerages
Source: Buzz FX / 23 Jan 2025 03:41:17 America/Chicago
Spyre Therapeutics, Inc. (NASDAQ:SYRE) Given Average Recommendation of "Buy" by Brokerages Written by MarketBeat January 23, 2025 Share Link copied to clipboard. Shares of Spyre Therapeutics, Inc. ( NASDAQ:SYRE - Get Free Report ) have earn
Read more...